During the past decade, Virginia Commonwealth University/Massey Cancer Center conducted 296 clinical trials. In the 10-year time frame, 296 clinical trials started and 215 clinical trials were completed, i.e. on average, 72.6% percent of trials that started reached the finish line to date. In the past 5 years, 137 clinical trials started and 107 clinical trials were completed. i.e. 78.1% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Virginia Commonwealth University/Massey Cancer Center" #1 sponsor was "National Cancer Institute (NCI)" with 200 trials, followed by "Alliance for Clinical Trials in Oncology" with 117 trials sponsored, "Children's Oncology Group" with 104 trials sponsored, "Virginia Commonwealth University" with 63 trials sponsored and "Radiation Therapy Oncology Group" with 63 trials sponsored. Other sponsors include 219 different institutions and companies that sponsored additional 78 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Virginia Commonwealth University/Massey Cancer Center" #1 collaborator was "National Cancer Institute (NCI)" with 437 trials as a collaborator, "NRG Oncology" with 49 trials as a collaborator, "SWOG Cancer Research Network" with 23 trials as a collaborator, "Cancer and Leukemia Group B" with 20 trials as a collaborator and "Canadian Cancer Trials Group" with 13 trials as a collaborator. Other collaborators include 167 different institutions and companies that were collaborators in the rest 96 trials.

According to Clinical.Site data, the most researched conditions in "Virginia Commonwealth University/Massey Cancer Center" are "Leukemia" (52 trials), "Breast Cancer" (50 trials), "Lymphoma" (49 trials), "Lung Cancer" (36 trials) and "Colorectal Cancer" (20 trials). Many other conditions were trialed in "Virginia Commonwealth University/Massey Cancer Center" in a lesser frequency.

Most popular intervention types in "Virginia Commonwealth University/Massey Cancer Center" are "Drug" (558 trials), "Other" (289 trials), "Biological" (216 trials), "Procedure" (204 trials) and "Radiation" (196 trials). Other intervention types were less common.

The name of intervention was led by "Laboratory Biomarker Analysis" (147 trials), "Quality-of-Life Assessment" (98 trials), "Questionnaire Administration" (82 trials), "radiation therapy" (68 trials) and "Biospecimen Collection" (56 trials). Other intervention names were less common.

The vast majority of trials in "Virginia Commonwealth University/Massey Cancer Center" are 600 trials for "All" genders, 119 trials for "Female" genders and 30 trials for "Male" genders.

Currently, there are NaN active trials in "Virginia Commonwealth University/Massey Cancer Center". undefined are not yet recruiting, 125 are recruiting, 174 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 364 completed trials in Virginia Commonwealth University/Massey Cancer Center, 14 suspended trials, and 51 terminated clinical trials to date.

Out of the total trials that were conducted in Virginia Commonwealth University/Massey Cancer Center, 75 "Phase 1" clinical trials were conducted, 317 "Phase 2" clinical trials and 307 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 52 trials that are defined as “Not Applicable".

Virginia Commonwealth University/Massey Cancer Center has several departments that took part in Clinical trials: "VCU Massey Cancer Center at Stony Point" - 67 trials, "VCU Massey Cancer Center at Hanover Medical Park" - 7 trials, "VCU Massey Cancer Center, Dalton Oncology Clinic" - 2 trials